Once-Daily, Single-Inhaler Mometasone-Indacaterol-Glycopyrronium vs Mometasone-Indacaterol or Twice-Daily Fluticasone-Salmeterol for Inadequately Controlled Asthma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Once-Daily, Single-Inhaler Mometasone-Indacaterol-Glycopyrronium Versus Mometasone-Indacaterol or Twice-Daily Fluticasone-Salmeterol in Patients With Inadequately Controlled Asthma (IRIDIUM): A Randomised, Double-Blind, Controlled Phase 3 Study
Lancet Respir Med 2020 Jul 09;[EPub Ahead of Print], HAM Kerstjens, J Maspero, KR Chapman, RN van Zyl-Smit, M Hosoe, AM Tanase, C Lavecchia, A Pethe, X Shu, P D'Andrea,From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.